These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 25704091)
1. Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits collagen synthesis in human hypertrophic scar fibroblasts by targeting Smad3 via miR-145. Zhu HY; Li C; Zheng Z; Zhou Q; Guan H; Su LL; Han JT; Zhu XX; Wang SY; Li J; Hu DH Biochem Biophys Res Commun; 2015 Mar; 459(1):49-53. PubMed ID: 25704091 [TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts. Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014 [TBL] [Abstract][Full Text] [Related]
3. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts. Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328 [TBL] [Abstract][Full Text] [Related]
4. Study on the role of Hsa-miR-31-5p in hypertrophic scar formation and the mechanism. Wang X; Zhang Y; Jiang BH; Zhang Q; Zhou RP; Zhang L; Wang C Exp Cell Res; 2017 Dec; 361(2):201-209. PubMed ID: 29056521 [TBL] [Abstract][Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro. Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY Arch Dermatol Res; 2009 Aug; 301(7):515-22. PubMed ID: 19466435 [TBL] [Abstract][Full Text] [Related]
6. [Effects of agonists of PPAR-gamma on angiotensin II-induced proliferation and extracellular matrix synthesis in hypertrophic scar fibroblasts]. Lin K; Lü L; Gao WY; He ZL; Zhang GY Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar; 29(2):121-5. PubMed ID: 23772491 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-98 inhibits the cell proliferation of human hypertrophic scar fibroblasts via targeting Col1A1. Bi S; Chai L; Yuan X; Cao C; Li S Biol Res; 2017 Jun; 50(1):22. PubMed ID: 28629444 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑185 regulates transforming growth factor‑β1 and collagen‑1 in hypertrophic scar fibroblasts. Xiao K; Luo X; Wang X; Gao Z Mol Med Rep; 2017 Apr; 15(4):1489-1496. PubMed ID: 28259900 [TBL] [Abstract][Full Text] [Related]
9. Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma. Ghosh AK; Wei J; Wu M; Varga J Biochem Biophys Res Commun; 2008 Sep; 374(2):231-6. PubMed ID: 18627765 [TBL] [Abstract][Full Text] [Related]
10. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells. Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-γ agonist inhibits collagen synthesis in human keloid fibroblasts by suppression of early growth response-1 expression through upregulation of miR-543 expression. Zhu HY; Bai WD; Wang HT; Xie ST; Tao K; Su LL; Liu JQ; Yang XK; Li J; Wang YC; He T; Han JT; Hu DH Am J Cancer Res; 2016; 6(6):1358-70. PubMed ID: 27429849 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes. Li Y; Shen Y; Li M; Su D; Xu W; Liang X; Li R Mol Cell Biochem; 2015 Jul; 405(1-2):233-41. PubMed ID: 25920446 [TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma interacts with CIITA x RFX5 complex to repress type I collagen gene expression. Xu Y; Farmer SR; Smith BD J Biol Chem; 2007 Sep; 282(36):26046-56. PubMed ID: 17611194 [TBL] [Abstract][Full Text] [Related]
14. PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1. Hou X; Zhang Y; Shen YH; Liu T; Song S; Cui L; Bu P Eur J Pharmacol; 2013 Sep; 715(1-3):196-203. PubMed ID: 23791613 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-9-5p inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting peroxisome proliferator-activated receptor β. Chai CY; Tai IC; Zhou R; Song J; Zhang C; Sun S Biol Open; 2020 Dec; 9(12):. PubMed ID: 33355167 [TBL] [Abstract][Full Text] [Related]
17. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315 [TBL] [Abstract][Full Text] [Related]
18. miR-145-5p attenuates hypertrophic scar via reducing Smad2/Smad3 expression. Shen W; Wang Y; Wang D; Zhou H; Zhang H; Li L Biochem Biophys Res Commun; 2020 Jan; 521(4):1042-1048. PubMed ID: 31732152 [TBL] [Abstract][Full Text] [Related]
19. PPARgamma agonists upregulate the barrier function of tight junctions via a PKC pathway in human nasal epithelial cells. Ogasawara N; Kojima T; Go M; Ohkuni T; Koizumi J; Kamekura R; Masaki T; Murata M; Tanaka S; Fuchimoto J; Himi T; Sawada N Pharmacol Res; 2010 Jun; 61(6):489-98. PubMed ID: 20227502 [TBL] [Abstract][Full Text] [Related]
20. Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive scar formation by inhibiting TGF-β2/Smad3 signaling. Yuan R; Dai X; Li Y; Li C; Liu L Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]